One of the most important areas of the biomedical field, IMO. Genomics affects so many applied areas of drug discovery, biotech, and other things that it is hard to compare to anything else.
Five Takeaways & Predictions
Perturb-Seq data is turning into industrial, reusable infrastructure
Personalized gene editing is drifting from “one therapy for many” toward modular platforms
Reproductive genomics is sliding from embryo screening toward embryo ranking
Cost and throughput keep dropping, making billion-cell screens/multi-omic atlases/population-scale programs economically plausible, and pushing competition toward reads-per-run/dollars-per-genome.
Genomics is expanding from reading and editing DNA to reconstructing and writing it at scale
For details and insights — read this deep dive by BiopharmaTrend